ACOG — Alpha Cognition Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1655923 ·
Last close
$9.75
Market Cap
$212.33M
52W High
$10.14
52W Low
$5.55
ADV30
134,794
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 3,533,798 | 3,262,022 | -8,096,227 | -6,478,018 | 69,248,341 | 54,248,275 | 11,791,836 |
| Dec 2025 | 2,793,076 | 2,540,827 | -7,925,270 | -6,856,306 | 79,730,235 | 66,046,789 | 17,200,060 |
| Sep 2025 | 2,840,858 | 2,212,797 | -5,301,986 | -1,318,074 | 46,301,213 | 35,398,899 | 12,387,403 |
| Jun 2025 | 1,657,687 | 1,123,590 | -5,737,001 | -10,488,952 | 45,122,942 | 39,405,210 | 13,226,626 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-30,134,079
Investing CF
$-231,541
Financing CF
$39,050,066
CapEx
$-231,541
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.38
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-103,584,793
Inventory
$6,043,714
Receivables
$3,752,090
ST Investments
—
EBIT TTM
$-27,060,484
Pretax Income TTM
$-25,141,350
Interest Exp TTM
$34,094
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$15,260,706
EBITDA
$-26,487,652
Free Cash Flow
$-28,530,086
Enterprise Value
$170,949,984
Total Cash
$41,384,288
Total Debt
$0
Shares Out
21,777,868
Trailing EPS
$-0.96
Book Value
$2.87
ROE
-49.5%
ROA
-30.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 10,220,275 | -22,579,594 | -20,669,875 | 79,730,235 | 17,200,060 | — | -20,380,367 |
| Dec 2024 | 0 | -11,548,636 | -14,788,727 | 50,736,938 | 11,642,111 | — | -7,755,654 |
| Dec 2023 | 0 | -9,617,813 | -13,763,658 | 2,452,170 | 7,155,865 | — | -8,799,565 |
| Dec 2022 | 0 | -13,465,624 | -12,114,698 | 2,950,951 | 4,271,128 | — | -9,241,650 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.62
Max Pain — expiry 2027-02-19 (volume-derived — Yahoo OI feed degraded)
max pain strike: $7.50 · spot: $9.75 · call volume: 15 · put volume: 25
Expected Move to 2027-02-19:
±$4.76
(48.82%) —
implied range
$4.99 –
$14.51
· ATM straddle on $10.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VYGR | Voyager Therapeutics, Inc. | $211.97M | $3.44 | — |
| CHRS | Coherus Oncology, Inc. | $210.12M | $1.36 | — |
| CRDL | Cardiol Therapeutics Inc. | $217.29M | $1.86 | — |
| ABOS | Acumen Pharmaceuticals, Inc. | $222.38M | $3.08 | — |
| TARA | Protara Therapeutics, Inc. | $228.70M | $3.87 | — |
News headlines (Yahoo Finance, 1h cache)
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) 2Q26
2026-08-17 14:43 · Yahoo
Alpha Cognition (ACOG) Stock Fair Value Rises After Zunveyl Analyst Optimism
2026-08-17 12:09 · Yahoo
Alpha Cognition (ACOG) Q2 2026 Earnings Call Transcript
2026-08-14 02:59 · Yahoo
Alpha Cognition Q2 Earnings Call Highlights
2026-08-13 22:04 · Yahoo
Alpha Cognition Inc. (ACOG) Reports Q2 Loss, Tops Revenue Estimates
2026-08-13 21:15 · Yahoo
Alpha Cognition to Report Second Quarter 2026 Financial Results and Provide Business Update
2026-08-03 12:30 · Yahoo
Alpha Cognition Receives European Patent Covering ZUNVEYL® for the Treatment of Mild-to-Moderate Alzheimer’s Disease
2026-07-29 12:30 · Yahoo
Alpha Cognition Inc. (ACOG) Surges 8.6%: Is This an Indication of Further Gains?
2026-07-28 10:55 · Yahoo
Raymond James Starts Alpha Cognition (ACOG) at Outperform
2026-07-14 18:08 · Yahoo
Alpha Cognition Announces Election of Dr. Robert Wills as Chairman of the Board
2026-06-23 12:30 · Yahoo
Recent Insider Activity
| Filed | Trade | Insider | Title | Type | Price | Qty | Value |
|---|---|---|---|---|---|---|---|
| 2026-08-24 14:52:45 | 2026-08-21 | Wills Robert James | Dir | P - Purchase | 9.62 | 10000 | 96200 |